You want to live in a Freedom City? Take a closer look at Honduras. Heather Sullivan - April 23, 2025 Próspera offers a cautionary tale on deregulation and charter cities.
For the first time, women will hold these four key congressional jobs Michele Swers - November 30, 2022 Women will lead the House and Senate appropriations committees in a highly contentious time. Will they do their jobs any differently than men might?
Oz has promoted false health claims. What if he pushed vaccinations? Matt Motta and Dominik Stecuła - October 16, 2022 When Oz urged viewers to vaccinate against the measles, many listened, our research finds
How will the end of Roe affect IVF? Nicole Kalaf-Hughes, Heather Mohamed, and Erin Heidt-Forsythe - June 16, 2022 Our research suggests that Republicans and Democrats want to preserve infertility care – although some laws could have unintended consequences.
If the Supreme Court undermines Roe v. Wade, contraception could be banned Rachel VanSickle-Ward and Kevin Wallsten - December 10, 2021 Constitutional protections for birth control could be on shaky ground.
Astrobrite, ‘Booster’: The Week In One Song Christopher Federico - October 22, 2021 More booster shots on the way.
The Supreme Court faces more pandemic questions this term. Here are 4 takeaways from last year’s rulings. Kyle Thomson, Herschel Nachlis, Annika Begley, and Amy Park - September 23, 2021 The court is skeptical about restrictions on religion and about mandates from ‘the administrative state’
As little as $20 in cash might persuade the reluctant to get vaccinated, our research finds Daniel J. Simmons and Carlos Algara - August 24, 2021 But employer mandates may harden opposition.
People are more anti-vaccine if they get their covid news from Facebook than from Fox News, data shows Roy H. Perlis, Matthew Simonson, Mauricio Santillana, Matthew Baum, Katherine Ognyanova, Jon Green, Jennifer Lin, James N. Druckman, David Lazer, and Ata Uslu - July 26, 2021 Biden said social media companies are ‘killing people’ by spreading vaccine misinformation
We’re seeing what happens when the FDA loses credibility Daniel Carpenter - July 20, 2021 It’s not just politicians who are worried about the decision to approve a new Alzheimer’s drug.